Effect of cocaine self-administration on striatal PKA-regulated signaling in male and female rats

Psychopharmacology (Berl). 2007 Apr;191(2):263-71. doi: 10.1007/s00213-006-0656-0. Epub 2006 Dec 16.

Abstract

Rationale: Chronic cocaine produces changes in the dopamine (DA)/D1/cAMP/protein kinase A (PKA)-regulated signaling pathway that may underlie the development of addiction.

Objective: Given sex differences in the progression to cocaine addiction, we examined the possibility that the PKA pathway is differentially activated by cocaine in male and female rats.

Materials and methods: Rats were given 24-h access to cocaine (1.5 mg/kg) or saline for 7 days under a discrete trial procedure (four trials per hour). Rats were then retested on responding for cocaine under a progressive-ratio schedule after either 0 (no-delay retest) or 10 (10-day-delay retest) days of abstinence. Markers of PKA-regulated signaling in the striatum and nucleus accumbens were evaluated by Western blotting, including phosphorylation of DA and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) at Thr 34 and glutamate receptor 1 (GluR1) at Ser 845.

Results: Compared to males, females had higher levels of DARPP-32 phosphorylated at the PKA site in the striatum. Increased phosphorylation of DARPP-32 at the PKA site was also seen in the nucleus accumbens of females compared to males, particularly among controls and rats tested after a 10-day abstinence period. DARPP-32 phosphorylation was also increased as a consequence of cocaine when tested after a 0-day abstinence period in male rats but not female rats.

Conclusion: These findings indicate sex differences in PKA-regulated signaling in drug-naïve controls. Furthermore, these data suggest that regulation of PKA signaling by cocaine is differentially influenced in male and female rats as a consequence of cocaine exposure and cocaine abstinence period.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Behavior, Animal
  • Blotting, Western
  • Cocaine / administration & dosage
  • Cocaine / pharmacology*
  • Cyclic AMP-Dependent Protein Kinases / drug effects*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dopamine Uptake Inhibitors / administration & dosage
  • Dopamine Uptake Inhibitors / pharmacology*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / drug effects*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Female
  • Male
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / enzymology
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / drug effects
  • Receptors, AMPA / metabolism
  • Self Administration
  • Sex Factors
  • Signal Transduction / drug effects*
  • Substance Withdrawal Syndrome

Substances

  • Dopamine Uptake Inhibitors
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Receptors, AMPA
  • Cyclic AMP-Dependent Protein Kinases
  • Cocaine
  • glutamate receptor ionotropic, AMPA 1